Fresh Recalls

Rapidol: recall status

Notice names this product. Dabur India’s Rapidol is named in FDA Class II recall D-0633-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: CGMP Deviations; deficiencies observed during FDA inspection Identifying details: Lot# 0004, within expiry. Units affected: 84 tubes. Status: Ongoing.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Rapidol
Company / brand
Dabur India
Lot / serial / date codes
Lot# 0004, within expiry
Distribution
US Nationwide.
Agency product description and boundaries

Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc 400 units, Neomycin Sulfate 3.5 mg, Polymyxin-B Sulfate 5,000 units, net wt. 2oz (57g) tubes, Distributed by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 10096 77162 9.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

Brand
Dabur India

Recalls naming this model

FDA Class II · Drug · June 24, 2026

Rapidol recall — Dabur India Limited

CGMP Deviations; deficiencies observed during FDA inspection

Company / brand: Dabur India

Affected product: Rapidol

Official ID D-0633-2026 · Official record ↗

See all Dabur India recalls →

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.